Analysis of symptoms and functional HRQoL scales in TAGS, a phase III trial of trifluridine/tipiracil (FTD/TPI) in metastatic gastric cancer (mGC).
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2019, vol.37, (Summary Text)
- Publication Type: Conference Paper / Summary Text
- Volume: 37
- Doi Number: 10.1200/jco.2019.37.15_suppl.4043
- City: Illinois
- Country: United States Of America
- Hacettepe University Affiliated: Yes